Business
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program
About this update from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment
View stock analysis, news, and events for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
More from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization
July 29, 2026
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Obtaining Orphan Drug Designation from the US FDA
July 27, 2026
All Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A news →